embelin has been researched along with Obesity in 5 studies
embelin: from Embelia fruit (Myrsinaceae)
embelin : A member of the class of dihydroxy-1,4-benzoquinones that is 2,5-dihydroxy-1,4-benzoquinone which is substituted by an undecyl group at position 3. Isolated from Lysimachia punctata and Embelia ribes, it exhibits antimicrobial, antineoplastic and inhibitory activity towards hepatitis C protease.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was designed to investigate the effect of embelin in metabolic endotoxemia (ME) mediated inflammation and associated obesity in high fat diet (HFD)-fed C57BL/6 mice." | 8.02 | Embelin modulates metabolic endotoxemia and associated obesity in high fat diet fed C57BL/6 mice. ( Arya, P; Bansal, P; Bhandari, U; Sharma, K, 2021) |
| "Recent studies suggest that Embelin, a natural plant extract might have the potential to prevent body weight gain in rats." | 7.85 | Embelin attenuates adipogenesis and lipogenesis through activating canonical Wnt signaling and inhibits high-fat diet-induced obesity. ( Gao, Y; Li, J; Li, X; Wang, B; Wang, S; Xu, X; Yang, Y; Zhang, L; Zheng, F; Zhou, J, 2017) |
| " The purpose of this study was to investigate the preventive effect of embelin against hyperlipidemia and oxidative stress in HFD-induced obesity in rats." | 7.78 | Preventive effect of embelin from embelia ribes on lipid metabolism and oxidative stress in high-fat diet-induced obesity in rats. ( Bhandari, U; Chaudhari, HS; Khanna, G, 2012) |
| "Chronic diseases are a serious health concern worldwide, especially in the elderly population." | 6.82 | Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases. ( Devi Daimary, U; Girisa, S; Kumar, A; Kunnumakkara, AB; Parama, D; Verma, E, 2022) |
| "The present study was designed to investigate the effect of embelin in metabolic endotoxemia (ME) mediated inflammation and associated obesity in high fat diet (HFD)-fed C57BL/6 mice." | 4.02 | Embelin modulates metabolic endotoxemia and associated obesity in high fat diet fed C57BL/6 mice. ( Arya, P; Bansal, P; Bhandari, U; Sharma, K, 2021) |
| "Recent studies suggest that Embelin, a natural plant extract might have the potential to prevent body weight gain in rats." | 3.85 | Embelin attenuates adipogenesis and lipogenesis through activating canonical Wnt signaling and inhibits high-fat diet-induced obesity. ( Gao, Y; Li, J; Li, X; Wang, B; Wang, S; Xu, X; Yang, Y; Zhang, L; Zheng, F; Zhou, J, 2017) |
| "These findings show that embelin could improve adipose tissue insulin sensitivity without increasing weight gain, enhance glycemic control, protect β-cell from damage and maintain glucose homeostasis in adipose tissue." | 3.79 | Insulin sensitization via partial agonism of PPARγ and glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway by embelin in type 2 diabetic rats. ( Balakrishna, K; Gandhi, GR; Ignacimuthu, S; Paulraj, MG; Stalin, A; Vishal, R, 2013) |
| " The purpose of this study was to investigate the preventive effect of embelin against hyperlipidemia and oxidative stress in HFD-induced obesity in rats." | 3.78 | Preventive effect of embelin from embelia ribes on lipid metabolism and oxidative stress in high-fat diet-induced obesity in rats. ( Bhandari, U; Chaudhari, HS; Khanna, G, 2012) |
| "Chronic diseases are a serious health concern worldwide, especially in the elderly population." | 2.82 | Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases. ( Devi Daimary, U; Girisa, S; Kumar, A; Kunnumakkara, AB; Parama, D; Verma, E, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devi Daimary, U | 1 |
| Girisa, S | 1 |
| Parama, D | 1 |
| Verma, E | 1 |
| Kumar, A | 1 |
| Kunnumakkara, AB | 1 |
| Bansal, P | 1 |
| Bhandari, U | 2 |
| Sharma, K | 1 |
| Arya, P | 1 |
| Gao, Y | 1 |
| Li, J | 1 |
| Xu, X | 1 |
| Wang, S | 1 |
| Yang, Y | 1 |
| Zhou, J | 1 |
| Zhang, L | 1 |
| Zheng, F | 1 |
| Li, X | 1 |
| Wang, B | 1 |
| Chaudhari, HS | 1 |
| Khanna, G | 1 |
| Gandhi, GR | 1 |
| Stalin, A | 1 |
| Balakrishna, K | 1 |
| Ignacimuthu, S | 1 |
| Paulraj, MG | 1 |
| Vishal, R | 1 |
1 review available for embelin and Obesity
| Article | Year |
|---|---|
Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases.
Topics: Benzoquinones; Chronic Disease; Embelia; Heart Diseases; Humans; Neoplasms; Obesity; X-Linked Inhibi | 2022 |
4 other studies available for embelin and Obesity
| Article | Year |
|---|---|
Embelin modulates metabolic endotoxemia and associated obesity in high fat diet fed C57BL/6 mice.
Topics: Adipose Tissue; Animals; Benzoquinones; Body Weight; Diet, High-Fat; Endotoxemia; Inflammation; Lipo | 2021 |
Embelin attenuates adipogenesis and lipogenesis through activating canonical Wnt signaling and inhibits high-fat diet-induced obesity.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Anti-Obesity Agents; Benzoquinones; Blotting, Weste | 2017 |
Preventive effect of embelin from embelia ribes on lipid metabolism and oxidative stress in high-fat diet-induced obesity in rats.
Topics: Animals; Anti-Obesity Agents; Antioxidants; Benzoquinones; Diet, High-Fat; Embelia; Fruit; Humans; H | 2012 |
Insulin sensitization via partial agonism of PPARγ and glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway by embelin in type 2 diabetic rats.
Topics: Adipose Tissue; Animals; Benzoquinones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; | 2013 |